文献速递创伤与烧伤复苏、休克与脓毒症

修订版加拿大出血(CAN-BLEED)评分用于出血创伤患者风险分层:一项混合回顾-前瞻性队列研究

The revised Canadian Bleeding (CAN-BLEED) score for risk stratification of bleeding trauma patients: a mixed retrospective-prospective cohort study.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2025-02-20
一句话结论修订版CAN-BLEED评分含8个变量,C统计量0.89,评分<2分排除需重大干预的敏感性97%(94-98%),尚需外部验证。

本研究为混合回顾-前瞻性队列研究,纳入2014年9月至2017年9月CAN-BLEED衍生研究回顾队列及2019年5月至2021年8月前瞻队列,共1368例创伤患者,旨在修订CAN-BLEED评分以预测出血创伤患者需重大干预(大量输血、栓塞或止血手术的复合终点)。总体重大干预发生率为17%,穿透伤占23%,中位损伤严重度评分17。修订评分含8个变量:收缩压、心率、乳酸、穿透机制、骨盆不稳定、FAST阳性游离液体、CT阳性游离液体或造影剂外渗,C统计量0.89,评分<2分排除重大干预的敏感性97%(94-98%)。作者认为该评分临床直观且内部验证性能优异,但需外部验证评估其表现。

要点

  • 修订版CAN-BLEED评分含8个变量:收缩压、心率、乳酸、穿透机制、骨盆不稳定、FAST阳性游离液体、CT阳性游离液体或造影剂外渗。
  • 评分<2分排除需重大干预(大量输血、栓塞或止血手术复合终点)的敏感性97%(94-98%)。
  • 简化评分C统计量0.89,用于识别创伤出血需重大干预的患者。
  • 队列总体重大干预发生率17%,穿透伤23%,中位损伤严重度评分17,共1368例。
  • 作者认为该评分临床直观且内部验证性能优异,但需外部验证评估其表现。

适用人群与场景

  • 出血创伤患者,包括回顾队列(2014年9月至2017年9月)和前瞻队列(2019年5月至2021年8月),共1368例;穿透伤占23%,中位损伤严重度评分17。

诊断标准与关键阈值

  • 修订版CAN-BLEED评分含8个变量:收缩压、心率、乳酸、穿透机制、骨盆不稳定、FAST阳性游离液体、CT阳性游离液体或造影剂外渗。
  • 评分<2分用于排除需重大干预,敏感性97%(94-98%)。

研究设计与关键结果

  • 研究为混合回顾-前瞻性队列研究,纳入1368例患者,主要终点为重大干预(大量输血、栓塞或止血手术的复合终点),总体发生率为17%。
  • 修订评分C统计量0.89;评分<2分排除重大干预的敏感性97%(94-98%)。
  • 采用逐步法和回归系数构建评分,bootstrap内部验证评估乐观校正性能。

证据类型、等级与局限

  • 证据类型:混合回顾-前瞻性队列研究,内部验证(bootstrap)。
  • 局限:原文报告需进一步努力进行外部验证以评估其表现。

对床旁实践的改变

  • 作者认为修订版CAN-BLEED评分临床直观且内部验证性能优异,可用于识别创伤出血需重大干预的患者;但需外部验证评估其表现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic hemorrhage is a significant cause of morbidity and mortality. There is considerable interest in risk stratification tools to aid with early activation of intervention pathways for bleeding patients. In this study, we refine the Canadian Bleeding (CAN-BLEED) score for the prediction of major interventions in bleeding trauma patients.

METHODS: We conducted a mixed retrospective-prospective cohort study. We included a retrospective cohort from the CAN-BLEED derivation study, from September 2014 to September 2017. We also conducted a prospective cohort from May 2019 to August 2021 and included both datasets for refinement of the CAN-BLEED score. The primary outcome was major intervention, defined by a composite of massive transfusion, embolization, or surgery for hemostasis. Predictors were pre-specified based on previous validation work. We used a stepdown procedure and regression coefficients to create a clinical risk stratification score. We used bootstrap internal validation to assess optimism-corrected performance.

RESULTS: We included 1368 patients in the overall cohort. Incidence of penetrating injury was 23% and median injury severity score was 17. The overall incidence of the need for major intervention was 17%. The revised score included 8 variables: systolic blood pressure, heart rate, lactate, penetrating mechanism, pelvic instability, Focused Abdominal Sonography for Trauma positive for free fluid, computed tomography positive for free fluid, or contrast extravasation. The C-statistic for the simplified score is 0.89. A score cut-off of less than 2 points yielded a 97% (94-98%) sensitivity in ruling out the need for major intervention.

CONCLUSION: The revised CAN-BLEED score offers a clinically intuitive and internally validated tool with excellent performance in identifying patients requiring major intervention for traumatic bleeding. Further efforts are required to evaluate its performance with an external validation.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Tran A, Lamb T, Fernando SM, et al. The revised Canadian Bleeding (CAN-BLEED) score for risk stratification of bleeding trauma patients: a mixed retrospective-prospective cohort study. Scand J Trauma Resusc Emerg Med. 2025. PMID: 39979932. doi:10.1186/s13049-025-01336-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。